Back to company

GALECTO BIOTECH ApS: Financial statements 2019

CVR: 34878366

GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,423,114 and a net result of DKK 323,877 compared with DKK -3,659,814 the year before. Equity amounted to DKK 2,690,360. The solvency ratio was 65.9%. The company had 11 employees in the financial year.

Gross Profit
2,423,114 kr.
Profit/Loss
323,877 kr.
Equity
2,690,360 kr.
Total Assets
4,084,968 kr.
Employees
11

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-2.4 mio.324 t.2.7 mio.11
2018--2.6 mio.-3.7 mio.-12.8 mio.5
2017--2.1 mio.-2.7 mio.-9.2 mio.4
2016--1.3 mio.-1.8 mio.-6.5 mio.-
2015-865 t.-504 t.-4.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

GALECTO BIOTECH ApS appoints new auditorMay 15, 2019

As of May 15, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of GALECTO BIOTECH ApS.

Auditor steps down at GALECTO BIOTECH ApSMay 15, 2019

As of May 15, 2019, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of GALECTO BIOTECH ApS.

GALECTO BIOTECH ApS: The 2018 annual report is outApr 3, 2019

GALECTO BIOTECH ApS has published its annual report for 2018. Gross profit came to DKK -2,569,142, and the net result was DKK -3,659,814.

About GALECTO BIOTECH ApS

GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees. In 2024, the company reported a gross profit of DKK 5,477,168 and a net result of DKK 310,297 compared with DKK 849,392 the year before. Equity amounted to DKK 8,553,704.